Dual protective role for Glutathione S-transferase class pi against VCD-induced ovotoxicity in the rat ovary
Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl ethyl sulfide is associated with increased production of reactive oxygen species
Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats
Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test
Developmental programming: Impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus
Impact of developmental lead exposure on splenic factors
Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes—An in vitro study
Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response
Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina
Multiple protein kinase pathways mediate amplified IL-6 release by human lung fibroblasts co-exposed to nickel and TLR-2 agonist, MALP-2
Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats
Multiple signal pathways in obesity-associated skin cancer
Response to the Letter to the Editor from Dr. Jiezhong Chen
Corrigendum to “Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice” [Toxicology and Applied Pharmacology (2009) 169–177],